Pharmaceuticals News and Research

RSS

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy.

8 Aug 2022

A GOP talking point suggests birth control is not at risk. Evidence suggests otherwise.

Republicans who oppose abortion have new talking points — birth control will remain easily available in the wake of the Supreme Court's decision overturning the federal right to abortion, and when Democrats say otherwise, they are just trying to scare voters.

5 Aug 2022

KAIST researchers engineer a bacterial strain capable of producing lutein

A research group at KAIST has engineered a bacterial strain capable of producing lutein. The research team applied systems metabolic engineering strategies, including substrate channeling and electron channeling, to enhance the production of lutein in an engineered Escherichia coli strain.

4 Aug 2022

Mice study reveals hepatic consequences of exposure to endocrine disrupting chemical mixtures

We are increasingly being exposed to endocrine-disrupting chemicals (EDCs) that interfere with the normal functioning of our hormones. Bisphenol A (BPA) and phthalates, which are widely used in consumer products including plastics, aluminum cans, pharmaceuticals, and cosmetics, are well-known EDCs.

4 Aug 2022

Study: Genes involved in coronary heart disease may be nearly the same for everyone

The genes involved in coronary heart disease, the most common form of heart disease, appear to be nearly the same for everyone, according to a VA study.

3 Aug 2022

Music festivals embrace overdose reversal drugs, but fentanyl testing kits remain taboo

A 26-year-old was found dead at his campsite during the Bonnaroo Music and Arts Festival in 2019. The toxicology report linked his death to a grim trend that has only worsened since.

3 Aug 2022

Substantial increases in cardiovascular trends contribute to a rising burden on the US health care system

By the year 2060, projected rates of cardiovascular risk factors and disease will increase significantly in the United States, according to a study published today in the Journal of the American College of Cardiology. Substantial increases in cardiovascular trends may contribute to a rising burden on the U.S. health care system and highlight the need for equitable access to prevention education and treatments now to prevent future disease.

3 Aug 2022

Improving dialogue between healthcare professionals and patients in bladder cancer

In this interview, Dr. Ignacio Duran and Alex Filicevas focus on improving dialogue between healthcare professionals and patients, outlining ways in which we can encourage open discussion to improve the overall patient experience.

From Janssen Pharmaceuticals 1 Aug 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

New method could lead to more efficient production of next-generation antibiotics

An international team of researchers has developed a method for altering one class of antibiotics, using microscopic organisms that produce these compounds naturally.

27 Jul 2022

Listen: Can California lower the price of insulin?

California Healthline senior correspondent Angela Hart appeared on KCRW's "Press Play With Madeleine Brand" and KJZZ, a public radio station in Phoenix, this month to discuss California's plan to reduce the cost of some prescription medications — starting with insulin — by diving into the generic drug market.

27 Jul 2022

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

Decreased hippocampal activity linked to worse PTSD symptoms

After a traumatic event, people with decreased activity in the hippocampus experience worse PTSD symptoms, according to new research published in JNeurosci.

25 Jul 2022

KHN’s ‘What the Health?’: Drug price bill is a go in the Senate

President Joe Biden is the latest top Washington official to test positive for covid-19, following Vice President Kamala Harris, Speaker of the House Nancy Pelosi, and Senate Majority Leader Chuck Schumer. But work continues, particularly on a Senate bill that could, for the first time, allow Medicare to negotiate prescription drug prices and cap seniors' out-of-pocket medication costs.

21 Jul 2022

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

The University of Texas MD Anderson Cancer Center and Obsidian Therapeutics, Inc. today announced Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for an MD Anderson-sponsored Phase I clinical study of OBX-115, Obsidian's lead engineered tumor infiltrating lymphocyte (TIL) therapy candidate.

21 Jul 2022

Parents become drug developers to save their children’s lives

Maggie Carmichael wasn't developing like other kids. As a toddler, she wasn't walking and had a limited vocabulary for her age.

21 Jul 2022

Study finds significant evidence for inaccurate and misleading labeling of CBD content

In a new study, Johns Hopkins Medicine researchers tested more than 100 topical cannabidiol (CBD) products available online and at retail stores, and found significant evidence of inaccurate and misleading labeling of CBD content.

20 Jul 2022

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine's (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.

19 Jul 2022

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.

18 Jul 2022

Previous
1
...
9
10
11
12
13
14
15
...
1247
Next

Pharmaceuticals News and Research

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

A GOP talking point suggests birth control is not at risk. Evidence suggests otherwise.

KAIST researchers engineer a bacterial strain capable of producing lutein

Mice study reveals hepatic consequences of exposure to endocrine disrupting chemical mixtures

Study: Genes involved in coronary heart disease may be nearly the same for everyone

Music festivals embrace overdose reversal drugs, but fentanyl testing kits remain taboo

Substantial increases in cardiovascular trends contribute to a rising burden on the US health care system

Improving dialogue between healthcare professionals and patients in bladder cancer

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Everything you need to know about Paxlovid — especially, should you take it?

New method could lead to more efficient production of next-generation antibiotics

Listen: Can California lower the price of insulin?

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Decreased hippocampal activity linked to worse PTSD symptoms

KHN’s ‘What the Health?’: Drug price bill is a go in the Senate

FDA clears IND application for MD Anderson-sponsored Phase I clinical study of OBX-115 therapy

Parents become drug developers to save their children’s lives

Study finds significant evidence for inaccurate and misleading labeling of CBD content

Six-country African study highlights the potential dangers of getting COVID-19 during pregnancy

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest Life Science News